EHC Encompass Health Corp
- Stocks
- Healthcare
- NYSE: EHC
Price (delayed)
$117.58
Market cap
$11.84B
P/E Ratio
22.66
Dividend/share
$0.68
EPS
$5.19
Enterprise value
$14.39B
Encompass Health Corporation , based in Birmingham, Alabama, is one of the United States' largest providers of post-acute healthcare services, offering both facility-based and home-based post-acute services in 36 states
Highlights
Encompass Health's net income has increased by 34% YoY and by 4.5% from the previous quarter
Encompass Health's EPS has increased by 31% YoY and by 6% from the previous quarter
Encompass Health's quick ratio has decreased by 22% YoY
The P/E is 8% above the 5-year quarterly average of 20.9 and 3.5% above the last 4 quarters average of 21.9
Key stats
What are the main financial stats of EHC
Market
Valuations
Earnings
Shares outstanding
100.72M
Market cap
$11.84B
Enterprise value
$14.39B
Price to earnings (P/E)
22.66
Price to book (P/B)
5.2
Price to sales (P/S)
2.09
EV/EBIT
15.21
EV/EBITDA
11.41
EV/Sales
2.54
Revenue
$5.67B
Gross profit
$1.5B
Operating income
$967.5M
Net income
$649.9M
EBIT
$946.2M
EBITDA
$1.26B
Free cash flow
$439.2M
Per share
Balance sheet
Liquidity
EPS
$5.19
EPS diluted
$5.11
Free cash flow per share
$4.37
Book value per share
$22.62
Revenue per share
$56.35
TBVPS
$51.56
Total assets
$6.79B
Total liabilities
$3.7B
Debt
$2.69B
Equity
$2.28B
Working capital
$53M
Debt to equity
1.18
Current ratio
1.06
Quick ratio
0.87
Net debt/EBITDA
2.02
Margins
Efficiency
Dividend
EBITDA margin
22.3%
Gross margin
26.5%
Net margin
11.5%
Operating margin
17.1%
Return on assets
9.8%
Return on equity
30.7%
Return on invested capital
14%
Return on capital employed
16%
Return on sales
16.7%
Dividend yield
0.58%
DPS
$0.68
Payout ratio
13.1%
EHC stock price
How has the Encompass Health stock price performed over time
Intraday
0.92%
1 week
8.34%
1 month
-0.47%
1 year
35.01%
YTD
27.32%
QTD
-4.12%
Financial performance
How have Encompass Health's revenue and profit performed over time
Revenue
$5.67B
Gross profit
$1.5B
Operating income
$967.5M
Net income
$649.9M
Gross margin
26.5%
Net margin
11.5%
Encompass Health's net income has increased by 34% YoY and by 4.5% from the previous quarter
Encompass Health's operating income has increased by 22% YoY and by 4.7% from the previous quarter
The net margin has grown by 20% YoY
EHC's gross profit is up by 18% YoY and by 4.1% from the previous quarter
Price vs fundamentals
How does EHC's price correlate with its fundamentals
Growth
What is Encompass Health's growth rate over time
Valuation
What is Encompass Health stock price valuation
P/E
22.66
P/B
5.2
P/S
2.09
EV/EBIT
15.21
EV/EBITDA
11.41
EV/Sales
2.54
Encompass Health's EPS has increased by 31% YoY and by 6% from the previous quarter
The P/E is 8% above the 5-year quarterly average of 20.9 and 3.5% above the last 4 quarters average of 21.9
The company's equity rose by 24% YoY and by 6% QoQ
EHC's price to book (P/B) is 21% higher than its 5-year quarterly average of 4.3 and 6% higher than its last 4 quarters average of 4.9
EHC's P/S is 23% above its 5-year quarterly average of 1.7 and 10% above its last 4 quarters average of 1.9
Encompass Health's revenue has increased by 12% YoY and by 2.8% QoQ
Efficiency
How efficient is Encompass Health business performance
Encompass Health's return on assets has increased by 24% YoY and by 2.1% QoQ
The ROIC has grown by 22% YoY and by 3.7% from the previous quarter
Encompass Health's ROS has increased by 10% YoY
Encompass Health's ROE has increased by 7% YoY
Dividends
What is EHC's dividend history
DPS
$0.68
Dividend yield
0.58%
Payout ratio
13.1%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Encompass Health financials performed over time
The total assets is 84% greater than the total liabilities
Encompass Health's quick ratio has decreased by 22% YoY
EHC's current ratio is down by 21% year-on-year
The debt is 18% more than the equity
Encompass Health's debt to equity has decreased by 26% YoY and by 6% from the previous quarter
The company's equity rose by 24% YoY and by 6% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.